Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

262 ARTíCULOS , VIENDO DEL 241 AL 255

PUBMED

A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.

Ciosi M, Maxwell A, Cumming SA, Hensman Moss DJ, Alshammari AM, Flower MD, Durr A, Leavitt BR, Roos RAC; TRACK-HD team.; Enroll-HD team., Holmans P, Jones L, Langbehn DR, Kwak S, Tabrizi SJ, Monckton

EBioMedicine. 2019 Oct 4. pii: S2352-3964(19)30624-3. doi: 10.1016/j.ebiom.2019.09.020. [Epub ahead of print]

0

0

0

PUBMED

Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis.

Morsy S, Khalil SM, Doheim MF, Kamel MG, El-Basiony DSM, Ahmed Hassan HI, Eisa AA, Anh Ngoc CT, Dang NP, Hirayama K, Huy NT.

Acta Neuropsychiatr. 2019 Aug;31(4):175-185. doi: 10.1017/neu.2019.11. Epub 2019 Mar 20.

0

0

0

PUBMED

Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.

Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J, Klempir J, Motlı K J, Juhas S, Ellederova Z.

Dis Model Mech. 2019 Dec 12;13(2). pii: dmm041293. doi: 10.1242/dmm.041293.

0

0

0

PUBMED

Induced pluripotent stem cells from Huntington's disease patients: a promising approach to define and correct disease-related alterations.

Fatima A, Gutiérrez-Garcia R, Vilchez D.

Neural Regen Res. 2019 May;14(5):769-770. doi: 10.4103/1673-5374.249223. No abstract available.

0

0

0

PUBMED

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.

Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I; PHAROS Investigators..

Clin Genet. 2019 May 15. doi: 10.1111/cge.13529. [Epub ahead of print]

0

0

0

PUBMED

The pathobiology of perturbed mutant huntingtin protein-protein interactions in Huntington's disease.

Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S.

J Neurochem. 2019 Nov;151(4):507-519. doi: 10.1111/jnc.14853. Epub 2019 Sep 15. Review.

0

0

0

PUBMED

Spatial memory in Huntington's disease: A comparative review of human and animal data.

Glikmann-Johnston Y, Fink KD, Deng P, Torrest A, Stout JC.

Neurosci Biobehav Rev. 2019 Mar;98:194-207. doi: 10.1016/j.neubiorev.2019.01.015. Epub 2019 Jan 15. Review.

0

0

0

PUBMED

Bim contributes to the progression of Huntington's disease-associated phenotypes.

Roberts SL, Evans T, Yang Y, Fu Y, Button RW, Sipthorpe RJ, Cowan K, Valionyte E, Anichtchik O, Li H, Lu B, Luo S.

Hum Mol Genet. 2019 Dec 9. pii: ddz275. doi: 10.1093/hmg/ddz275. [Epub ahead of print]

0

0

0

PUBMED

Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.

Irvine EE, Katsouri L, Plattner F, Al-Qassab H, Al-Nackkash R, Bates GP, Withers DJ.

Sci Rep. 2019 Nov 6;9(1):16133. doi: 10.1038/s41598-019-52391-3.

0

0

0

PUBMED

Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.

Cho IK, Yang B, Forest C, Qian L, Chan AWS.

PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.

0

0

0

PUBMED

Application of an in vitro Blood Brain Barrier model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.

Di Marco A, Gonzalez Paz O, Fini I, Vignone D, Cellucci A, Battista MR, Auciello G, Orsatti L, Zini M, Monteagudo E, Khetarpal V, Rose M, Dominguez C, Herbst T, Toledo-Sherman L, Summa V, Muñoz-Sanjua

Mol Pharm. 2019 Mar 27. doi: 10.1021/acs.molpharmaceut.9b00042. [Epub ahead of print]

0

0

0

PUBMED

Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.

Carlozzi NE, Boileau NR, Hahn EA, Barton SK, Cella D, McCormack MK, Ready RE.

J Huntingtons Dis. 2019 Nov 11. doi: 10.3233/JHD-190385. [Epub ahead of print]

0

0

0

PUBMED

The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson's disease and Huntington's disease: Two meta-analyses.

Ghielen I, Rutten S, Boeschoten RE, Houniet-de Gier M, van Wegen EEH, van den Heuvel OA, Cuijpers P.

J Psychosom Res. 2019 Jul;122:43-51. doi: 10.1016/j.jpsychores.2019.05.001. Epub 2019 May 13. Review.

0

0

0

PUBMED

Multimodal characterization of the visual network in Huntington's disease gene carriers.

Gregory S, Odish OFF, Mayer I, Mills J, Johnson EB, Scahill RI, Rothwell J, Rees G, Long JD, Tabrizi SJ, Roos RAC, Orth M.

Clin Neurophysiol. 2019 Nov;130(11):2053-2059. doi: 10.1016/j.clinph.2019.08.018. Epub 2019 Aug 28.

0

0

0

PUBMED

PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.

Lloret A, Beal MF.

Neurochem Res. 2019 May 7. doi: 10.1007/s11064-019-02809-1. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy